Etravirine in treatment‐experienced, HIV‐1‐infected children and adolescents: 48‐week safety, efficacy and resistance analysis of the phase II PIANO study
Tudor‐Williams, G, Cahn, P, Chokephaibulkit, K, Fourie, J, Karatzios, C, Dincq, S, Opsomer, M, Kakuda, TN, Nijs, S, Tambuyzer, L, Tomaka, FL
Published in HIV medicine (01.10.2014)
Published in HIV medicine (01.10.2014)
Get full text
Journal Article
Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged ≥ 3 to <12 Years: Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations
Brochot, A, Kakuda, TN, Van De Casteele, T, Opsomer, M, Tomaka, FL, Vermeulen, A, Vis, P
Published in CPT: pharmacometrics and systems pharmacology (01.07.2015)
Published in CPT: pharmacometrics and systems pharmacology (01.07.2015)
Get full text
Journal Article
Model‐Based Once‐Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV‐1‐Infected Patients Aged ≥3 to <12 Years
Brochot, A, Kakuda, TN, Van De Casteele, T, Opsomer, M, Tomaka, FL, Vermeulen, A, Vis, P
Published in CPT: pharmacometrics and systems pharmacology (01.07.2015)
Published in CPT: pharmacometrics and systems pharmacology (01.07.2015)
Get full text
Journal Article